Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Vues
• 07/30/23
0
0
Intégrer
administrator
Les abonnés
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires